Therapeutic potential of combination therapy of soluble VEGF receptor 1 and conventional chemotherapy for ovarian cancer growth.

Sato, Noriko; Kumasawa, Keiichi; Yamashita, Michiko; Miyake, Tatsuya; Nakamura, Hitomi; Kimura, Tadashi

Sato, Noriko; Kumasawa, Keiichi; Yamashita, Michiko; Miyake, Tatsuya; Nakamura, Hitomi; Kimura, Tadashi.

Affiliation

Sato N; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.
Kumasawa K; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.
Yamashita M; Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Miyake T; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.
Nakamura H; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.
Kimura T; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.

J Obstet Gynaecol Res ; 46(4): 636-645, 2020 Apr.

Article de En | MEDLINE | ID: mdl-32022375

Sujet(s)
Mots clés

SKOV3; carboplatin; cytotoxicity; ovarian cancer; sFlt1

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Protocoles de polychimiothérapie antinéoplasique / Carboplatine / Récepteur-1 au facteur croissance endothéliale vasculaire Limites: Female / Humans Langue: En Journal: J Obstet Gynaecol Res Sujet du journal: GINECOLOGIA / OBSTETRICIA Année: 2020 Type de document: Article Pays d'affiliation: Japon

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google